Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Antifungal Use in Oncohematological Neutropenic Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Active				2 and over				Other				2005-004973-55 ANTIVORIFUNGOL, NCT00386802


2.		Immediate vs Deferred Empirical Antifungal Treatment With Voriconazole in Neutropenic Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				Pharmaceutical / Industry				A1501029 NCT00150345


3.		Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				16 and over				Pharmaceutical / Industry				A8851009 NCT00531479


4.		Antifungal Prophylaxis in Pediatric Acute Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				15 and younger				Other				antifungal prophylaxis Dr. SAMEER BAKHSHI, NCT00624143

Last Modified: 10/23/2007 First Published: 10/7/2005


5.		Phase II Study of Voriconazole and Caspofungin Acetate in Immunocompromised Patients With Invasive Fungal Infections

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				18 and over				NCI				OHSU-HEM-0346-L OHSU-IRB-1379, NCT00238355


6.		Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				18 and over				Other				2006-0536 NCT00418951

Last Modified: 12/12/2007 First Published: 12/8/2006


7.		Pilot Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity in Adults and Children

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Natural history/Epidemiology				Active				8 and over				NCI				NCI-06-C-0198 NCI-P6963, NCT00411008


8.		Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Active				15 to 65				Other				VCZ_TDM_Korea NCT00673348

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute